Summary: In patients with type 2 diabetes, stratified by ApoE genotype (E2/E3, E3/E3, E3/E4, and E4/E4 carriers), flaxseed oil supplementation…
Browsing: PICO
Clinical Context Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) affects up to 70-80% of patients with type 2 diabetes,…
Clinical Context Exercise is a cornerstone of type 2 diabetes management, improving glycemic control, cardiovascular risk factors, and overall fitness.…
Clinical Context Cardiovascular disease remains the leading cause of death in type 2 diabetes, driven by diabetic dyslipidemia—a characteristic pattern…
Summary: In adults diagnosed with chronic high-altitude disease living at high elevation, hydrogen-rich water (HRW) supplementation for 60 days as…
Clinical Context Cardiac rehabilitation (CR) is a cornerstone of secondary prevention in coronary artery disease, reducing cardiovascular mortality by approximately…
Clinical Context Charcot neuroarthropathy (CN) is a devastating complication of peripheral neuropathy, most commonly occurring in diabetes. Progressive bone destruction,…
Clinical Context Gestational diabetes mellitus (GDM) affects 6-15% of pregnancies and is increasing in prevalence alongside the obesity epidemic. GDM…
Clinical Context SGLT2 inhibitors have demonstrated cardiovascular benefits that aren’t fully explained by glucose lowering alone. Standard lipid panels (LDL-C,…
Clinical Context Pregnancy in type 1 diabetes (T1D) requires meticulous glycemic management. Insulin requirements increase dramatically across gestation—typically 50-100% above…
